The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-N-(3-(2-amino-6-(fluoromethyl)-4-methyl-4H-1,3-oxazin-4-yl)-4-fluorophenyl)-5-methoxy-3-methylpyrazine-2-carboxamide ID: ALA5285805
Max Phase: Preclinical
Molecular Formula: C19H19F2N5O3
Molecular Weight: 403.39
Associated Items:
Names and Identifiers Canonical SMILES: COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)C=C(CF)OC(N)=N3)c2)c(C)n1
Standard InChI: InChI=1S/C19H19F2N5O3/c1-10-16(23-9-15(24-10)28-3)17(27)25-11-4-5-14(21)13(6-11)19(2)7-12(8-20)29-18(22)26-19/h4-7,9H,8H2,1-3H3,(H2,22,26)(H,25,27)/t19-/m0/s1
Standard InChI Key: VYZICWXJOCPCSB-IBGZPJMESA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
-1.0715 -0.4129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0715 -1.2379 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7860 -0.0003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7860 0.8282 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5025 1.2363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2126 0.8245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2126 -0.0007 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5006 -0.4127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5006 -1.2377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9271 1.2370 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.6416 0.8245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3569 -0.0003 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3574 -0.4129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3574 -1.2412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0737 -1.6492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7837 -1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4981 -1.6500 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.7837 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4981 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2127 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2127 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2127 1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9272 1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6416 1.2375 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.4982 1.6500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7837 1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0692 1.6500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7837 0.4125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0719 -0.0006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 3 1 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 3 2 0
8 9 1 0
6 10 1 0
10 11 1 0
1 12 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 1 0
16 18 2 0
19 18 1 1
19 20 1 0
19 21 1 0
21 22 2 0
22 23 1 0
23 24 1 0
22 25 1 0
25 26 1 0
26 27 1 0
26 28 2 0
28 19 1 0
18 29 1 0
29 13 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 403.39Molecular Weight (Monoisotopic): 403.1456AlogP: 2.60#Rotatable Bonds: 5Polar Surface Area: 111.72Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.83CX Basic pKa: 5.57CX LogP: 1.71CX LogD: 1.71Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.79Np Likeness Score: -0.90
References 1. Oguma T, Uehara S, Nakahara K, Okuyama Y, Fuchino K, Suzuki N, Kan Y, Kanegawa N, Ogata Y, Kusakabe KI.. (2023) A Quantum Mechanics-Based Method to Predict Intramolecular Hydrogen Bond Formation Reflecting P-glycoprotein Recognition., 14 (2.0): [PMID:36793434 ] [10.1021/acsmedchemlett.2c00427 ]